These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6723114)

  • 1. Epidemic dialysis encephalopathy.
    Hocken AG
    Clin Nephrol; 1984 Feb; 21(2):140. PubMed ID: 6723114
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive dialysis encephalopathy from dialysate aluminum.
    Rozas VV; Port FK; Rutt WM
    Arch Intern Med; 1978 Sep; 138(9):1375-7. PubMed ID: 686928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 4. [Water purification in dialysis treatment. Aluminum and encephalopathy].
    Hagstam KE; Lindergård B; Lindholm T; Thysell H
    Lakartidningen; 1980 Jun; 77(26-27):2425-7. PubMed ID: 7401791
    [No Abstract]   [Full Text] [Related]  

  • 5. Dialysis encephalopathy associated with polyvalent ion contamination.
    Hocken AG
    N Z Med J; 1984 Mar; 97(752):190-2. PubMed ID: 6583579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
    Milne FJ; Sharf B; Bell P; Meyers AM
    Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
    Arze RS; Parkinson IS; Cartlidge NE; Britton P; Ward MK
    Lancet; 1981 Nov; 2(8255):1116. PubMed ID: 6118567
    [No Abstract]   [Full Text] [Related]  

  • 9. Aluminium studies in dialysis encephalopathy.
    Elliott HL; Macdougall AI
    Proc Eur Dial Transplant Assoc; 1978; 15():157-63. PubMed ID: 740662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminium: removal from water supplies.
    Parkinson IS; Beckett A; Ward MK; Feest TG; Hoenich N; Strong A; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():586-7. PubMed ID: 740691
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 13. Aluminum binding to organic acids and plasma proteins. Implications for dialysis encephalopathy.
    Trapp GA
    J Environ Pathol Toxicol Oncol; 1985; 6(1):15-20. PubMed ID: 4067831
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neurologic complications in hemodialysis patients].
    Goulon-Goeau C; Saïd G
    Rev Prat; 1990 Mar; 40(7):644-6. PubMed ID: 2326590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aluminum and the encephalopathy of hemodialysis patients].
    Cartier F; Guenel J; Chatel M
    Nephrologie; 1981; 2(3):89-91. PubMed ID: 7301033
    [No Abstract]   [Full Text] [Related]  

  • 16. Dialysis encephalopathy.
    Masramón J; Ricart MJ; Caralps A; Lloveras J; Andreu J; Brulles A; Solá R
    Lancet; 1978 Jun; 1(8078):1370. PubMed ID: 78143
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive dialysis encephalopathy. Role of aluminum toxicity.
    Poisson M; Mashaly R; Lafforgue B
    Ann Neurol; 1979 Jul; 6(1):88. PubMed ID: 507770
    [No Abstract]   [Full Text] [Related]  

  • 18. Dialysis encephalopathy.
    Alfrey AC
    Clin Nephrol; 1985; 24 Suppl 1():S15-9. PubMed ID: 3915955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum.
    Gacek EM; Babb AL; Uvelli DA; Fry DL; Scribner BH
    Trans Am Soc Artif Intern Organs; 1979; 25():409-15. PubMed ID: 43004
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Aluminium and dialysis encephalopathy.
    Platts MM; Hislop JS
    Lancet; 1976 Jul; 2(7976):98. PubMed ID: 59177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.